Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04498143 · ClinicalTrials.gov registry record · NA
Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents
A NA study, sponsored by University of Denver.
- Completed
- Registry status
- NA
- Development phase
- 565
- Enrollment target
NCT04498143: Completed NA study, sponsored by University of Denver.
NCT04498143 is a NA study that has completed, run by University of Denver. The registered enrollment target is 565 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04498143, a NA study, has completed, sponsored by University of Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 565 participants
- Enrollment target
Study Summary
Participants (aged 13-16) will be randomized to: (1) an online, active control group program encouraging feelings disclosure (i.e. supportive therapy single session intervention \[SSI\]), or (2) an online program targeting nonsuicidal self-injury (NSSI; i.e. Project "SAVE"-Stop Adolescent Violence Everywhere-SSI). Investigators will test whether SAVE results in significantly greater: 1. Reductions in NSSI 3 months post-treatment \[primary outcome\] 2. Reductions in self-reported likelihood of future NSSI immediately post-treatment \[secondary outcome\] 3. Reduction in suicide ideation frequency 3 months post-treatment \[secondary outcome\]
Primary Outcome
Our primary outcome variable will compare past 3-month Nonsuicidal self-injury (NSSI) frequency at 3-month follow-up-for participants assigned to the Project SAVE single session intervention versus supportive therapy single session intervention (i.e. control condition). Participants will indicate "how many times they have purposely hurt themselves without wanting to die" in the past 3 months in an open-response text box. Notably, in the present study's survey flow, this question is displayed fol
Interventions
- OTHER Project SAVE ("Stop Adolescent Violence Everywhere") SSI
- OTHER Active Comparator: Supportive Therapy ("Share Your Feelings") SSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2020-08-18 |
| Est. Completion | 2021-04-14 |
| Phase | NA |
What the finished NCT04498143 record still lists
NCT04498143 is an interventional study that assigns participants to a tested intervention. The registered 565 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which Project SAVE ("Stop Adolescent Violence Everywhere") SSI is the first listed.
NCT04498143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04498143 about?
NCT04498143 is a clinical study titled "Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents". Participants (aged 13-16) will be randomized to: (1) an online, active control group program encouraging feelings disclosure (i.e. supportive therapy single session intervention \[SSI\]), or (2) an online program targeting nonsuicidal self-injury (NSSI; i.e. Project "SAVE"-Stop Adolescent Violence E...
What is the current status of trial NCT04498143?
This trial is currently completed. It is a NA study. The enrollment target is 565 participants. The study started on 2020-08-18. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT04498143?
The interventions under investigation include: Project SAVE ("Stop Adolescent Violence Everywhere") SSI (OTHER), Active Comparator: Supportive Therapy ("Share Your Feelings") SSI (OTHER).
Who is sponsoring clinical trial NCT04498143?
This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04498143's enrollment target sits among peer trials
565 180th of 2000 higher than 1,821 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI